Today: 19 May 2026
Browse Category

BSE:511218 17 December 2025 - 24 December 2025

Shriram Finance Share Price Today (24 Dec 2025): Stock Hits Fresh 52-Week High as MUFG Deal Fuels Rerating — Analyst Targets Up to ₹1,225

Shriram Finance Share Price Today (24 Dec 2025): Stock Hits Fresh 52-Week High as MUFG Deal Fuels Rerating — Analyst Targets Up to ₹1,225

Shriram Finance traded near ₹977 midday Wednesday, hitting a new 52-week high after MUFG agreed to acquire a 20% stake for $4.4 billion. The deal, via a preferential issue at ₹840.93 per share, awaits shareholder and regulatory approval. An EGM is set for January 14, 2026. MUFG will get minority protection rights and pay a $200 million non-compete fee to Shriram Ownership Trust.
24 December 2025
··
Shriram Finance Share Price Hits Record High on MUFG’s $4.4 Billion Stake Deal: Latest News, Analyst Targets, and Stock Outlook (Dec 22, 2025)

Shriram Finance Share Price Hits Record High on MUFG’s $4.4 Billion Stake Deal: Latest News, Analyst Targets, and Stock Outlook (Dec 22, 2025)

Shriram Finance shares surged to a record high of ₹947.70 on December 22 after Mitsubishi UFJ Financial Group agreed to invest $4.4 billion for a 20% stake via a preferential equity issue at ₹840.93 per share. The deal, pending shareholder and regulatory approvals, marks the largest cross-border investment in India’s financial sector. Shriram Finance will seek shareholder approval at an EGM on January 14, 2026.
22 December 2025
··
Shriram Finance Share Price Outlook (Dec 21, 2025): MUFG’s $4.4 Billion Stake Deal, Analyst Targets, and What Happens Next

Shriram Finance Share Price Outlook (Dec 21, 2025): MUFG’s $4.4 Billion Stake Deal, Analyst Targets, and What Happens Next

Japan’s MUFG will acquire a 20% stake in Shriram Finance for about $4.4 billion via a preferential allotment, pending shareholder and regulatory approval. Shriram Finance shares surged to record highs Friday, closing near ₹901.7. The deal includes a $200 million non-compete fee for Shriram Ownership Trust and grants MUFG minority protection rights and board representation. An EGM is set for January 14, 2026.
21 December 2025
··

Stock Market Today

  • Dr Martens Shares Rise on Profit Growth Amid Turnaround Signs
    May 19, 2026, 7:52 AM EDT. Dr Martens (LSE: DOCS) shares jumped nearly 6% after reporting a 61% rise in adjusted profit before tax (PBT) for fiscal year 2026, signaling a return to profit growth under CEO Ije Nwokorie. Despite an 84% share price drop since its 2021 IPO, the firm is shifting to a consumer-first model with strong brand collaborations and improved performance in the Americas. While management withheld specific guidance for FY27, analysts predict earnings growth could reduce the price-to-earnings ratio to 10 by 2028. The company maintains a 2.55p dividend, yielding 4%, reflecting cautious cash management amid supply chain cost controls. Investors are watching to see if this marks a sustainable turnaround for the iconic footwear brand.

Latest articles

MetaVia Stock Moves Ahead of the Open After Obesity-Drug Data Picked for ADA

MetaVia Stock Moves Ahead of the Open After Obesity-Drug Data Picked for ADA

19 May 2026
Diploma PLC shares rose 4.75% to 6,940p after the company raised its 2026 outlook, citing strong demand and a 17% rise in first-half revenue to £851.1 million. Adjusted operating profit climbed 33% to £208.9 million, and the interim dividend increased 5% to 19.1p. The Controls division posted 26% organic growth. Diploma completed 15 acquisitions worth about £310 million in the past year.
Zeta Global Pops Again as Traders Eye OpenAI Ad Deal

Zeta Global Pops Again as Traders Eye OpenAI Ad Deal

19 May 2026
Zeta Global shares rose 3.4% to $19.85 in premarket trading Tuesday after CEO David Steinberg announced an advertising agreement with OpenAI at a JPMorgan conference. The stock had closed up 11.6% at $19.19 on Monday, trading over 17 million shares. Bank of America reinstated coverage with a Buy rating and $24 target. Zeta recently reported first-quarter revenue up 50% year-over-year to $396 million.
Home Depot Earnings Show Housing Stress for Wall Street

Home Depot Earnings Show Housing Stress for Wall Street

19 May 2026
Home Depot reported first-quarter sales of $41.8 billion, up 4.8%, beating estimates, but comparable sales rose just 0.6%, missing analyst forecasts. Net earnings fell to $3.3 billion from $3.4 billion a year earlier. The company kept its 2026 outlook unchanged. Shares edged higher in premarket trading.

Popular

Regeneron stock sinks after cancer trial miss prompts selloff

Regeneron stock sinks after cancer trial miss prompts selloff

19 May 2026
Regeneron Pharmaceuticals shares fell 9.8% to $629.68 Monday after its late-stage melanoma drug trial with fianlimab failed to meet the main goal. The study did not show a statistically significant benefit over Merck’s Keytruda. At least 10 brokerages cut price targets. The decline outpaced broader market losses, with the Nasdaq down 0.5%.
Go toTop